NASDAQ:MBOT Microbot Medical (MBOT) Stock Price, News & Analysis $1.07 -0.07 (-6.14%) Closing price 11/5/2026 04:00 PM EasternExtended Trading$1.10 +0.03 (+2.71%) As of 11/5/2026 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsNews and TrendsOptions ChainOwnershipSEC Filings About Microbot Medical Stock (NASDAQ:MBOT) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Microbot Medical alerts:Sign Up Key Stats Today's Range$1.03▼$1.1650-Day Range$0.94▼$1.5052-Week Range$0.93▼$2.86Volume1.44 million shsAverage Volume808,288 shsMarket Capitalization$71.87 millionP/E RatioN/ADividend YieldN/APrice Target$5.08Consensus RatingModerate Buy Company Overview Microbot Medical Inc. (NASDAQ: MBOT) is a medical-device company developing robotic technologies for minimally invasive vascular procedures. Its systems are designed to help physicians remotely control guidewires and catheters during endovascular interventions, with the potential to improve procedural control and reduce clinicians’ exposure to radiation. The company’s primary product candidate is the LIBERTY Endovascular Robotic System, a compact, single-use robotic platform intended to support peripheral and neurovascular procedures. Microbot Medical has also pursued additional robotic technologies, including systems designed to simplify and improve the delivery of interventional devices. The company’s products remain subject to applicable regulatory requirements and clinical development. Microbot Medical was established in Israel and has developed its business through a combination of internal research and strategic corporate transactions. The company maintains operations in the United States and Israel and is led by Harel Gadot, who serves as chairman, president and chief executive officer.AI Generated. May Contain Errors. Read More Microbot Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks69th Percentile Overall ScoreMBOT MarketRank™: 3.43607305936 of 5 starsMicrobot Medical scored higher than 69% of companies evaluated by MarketBeat, and ranked 190th out of 891 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.3 / 5Analyst RatingModerate Buy Consensus RatingMicrobot Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.57, and is based on no strong buy ratings, 5 buy ratings, 1 hold rating, and 1 sell rating.Upside PotentialMicrobot Medical has a consensus price target of $5.08, representing about 375.1% upside from its current price of $1.07.Amount of Analyst CoverageMicrobot Medical has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Microbot Medical's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Microbot Medical are expected to grow in the coming year, from ($0.30) to ($0.28) per share.Price to Book Value per Share RatioMicrobot Medical has a P/B Ratio of 0.93. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Microbot Medical's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted9.36% of the float of Microbot Medical has been sold short.Short Interest Ratio / Days to CoverMicrobot Medical has a short interest ratio ("days to cover") of 6.57.Change versus previous monthShort interest in Microbot Medical has recently decreased by 9.80%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldMicrobot Medical does not currently pay a dividend.Dividend GrowthMicrobot Medical does not have a long track record of dividend growth. News and Social Media2.0 / 5News Sentiment0.24 News SentimentMicrobot Medical has a news sentiment score of 0.24. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.39 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Microbot Medical this week, compared to 2 articles on an average week.Search InterestOnly 3 people have searched for MBOT on MarketBeat in the last 30 days. This is a decrease of -73% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Microbot Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of -80% compared to the previous 30 days. Company Ownership0.4 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Microbot Medical insiders have not sold or bought any company stock.Percentage Held by Insiders4.74% of the stock of Microbot Medical is held by insiders.Percentage Held by Institutions16.30% of the stock of Microbot Medical is held by institutions.Read more about Microbot Medical's insider trading history. Receive MBOT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Microbot Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MBOT Stock News HeadlinesMicrobot Medical Adds Canadian Patent to IP Portfolio46 minutes ago | finance.yahoo.comMicrobot Medical® Strengthens IP Portfolio as it Continues to Establish Infrastructure to Support Future Commercialization ExpansionNovember 5 at 8:30 AM | globenewswire.comDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the 64 trillion dollar question: is a stock market crash on the way. Weiss Ratings analysts say 2026 could be rough for a number of well known stocks as a major shift takes shape in the market. They have pinpointed five stocks investors may want to watch closely before the opening bell. | Weiss Ratings (Ad)Microbot Medical (MBOT) Stock Sees Fair Value Cut As Liberty Adoption Outlook SoftensNovember 3 at 10:49 AM | finance.yahoo.comMicrobot Medical consensus price target lowered by 15.63% to $5.74November 2 at 12:47 AM | msn.comMicrobot Medical® Secures its First Office-Based Lab (OBL) Customer for the LIBERTY® Endovascular Robotic SystemOctober 27, 2026 | globenewswire.comMicrobot Medical® Attending Key Medical Conference to Engage with Decision-makers as it Continues to Expand Presence Across the U.S.October 23, 2026 | globenewswire.comMicrobot Medical Expands Global Patent Portfolio for LIBERTYOctober 20, 2026 | tipranks.comSee More Headlines MBOT Stock Analysis - Frequently Asked Questions How have MBOT shares performed this year? Microbot Medical's stock was trading at $2.00 at the beginning of 2026. Since then, MBOT shares have decreased by 46.5% and is now trading at $1.07. How were Microbot Medical's earnings last quarter? Microbot Medical Inc. (NASDAQ:MBOT) posted its quarterly earnings results on Tuesday, August, 11th. The biotechnology company reported ($0.08) EPS for the quarter, missing the consensus estimate of ($0.08) by $0.00. The biotechnology company had revenue of $241 thousand for the quarter, compared to analyst estimates of $133 thousand. When did Microbot Medical's stock split? Microbot Medical's stock reverse split before market open on Monday, May 9th 2016.The 1-12 reverse split was announced on Friday, May 6th 2016. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 6th 2016. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split. How do I buy shares of Microbot Medical? Shares of MBOT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Microbot Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Microbot Medical investors own include NVIDIA (NVDA), Tesla (TSLA), Advanced Micro Devices (AMD), Plug Power (PLUG), Micron Technology (MU), Qualcomm (QCOM) and Gilead Sciences (GILD). Company Calendar Last Earnings8/11/2026Today11/05/2026Next Earnings (Estimated)11/11/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (3m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 MBOT's financial health is in the Red zone, according to TradeSmith. MBOT has been in this zone for over 3 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:MBOT CIK883975 Webwww.microbotmedical.com Phone(908) 938-5561Fax781-556-5347Employees22Year Founded2010Price Target and Rating Average Price Target for Microbot Medical$5.08 High Price Target$12.00 Low Price Target$2.50 Potential Upside/Downside+375.1%Consensus RatingModerate Buy Rating Score (0-4)2.57 Research Coverage7 Analysts Profitability EPS (Trailing Twelve Months)($0.24) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$13.14 million Net MarginsN/A Pretax Margin-4,722.25% Return on Equity-21.87% Return on Assets-20.76% Debt Debt-to-Equity RatioN/A Current Ratio18.56 Quick Ratio17.82 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$1.15 per share Price / Book0.93Miscellaneous Outstanding Shares67,170,000Free Float63,981,000Market Cap$71.87 million OptionableOptionable Beta1.07 Social Links Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report This page (NASDAQ:MBOT) was last updated on 11/5/2026 by MarketBeat.com Staff. From Our PartnersI'm handing you this one freeElon Musk doesn't own the chip powering every Tesla, every Starlink dish, and every AI satellite he builds, he...Behind the Markets | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredMany investors are about to lose everythingTwenty five years ago, this analyst predicted the fiber optic boom and called Amazon before it became a househ...Porter & Company | SponsoredIf you keep cash in a U.S. bank account… read this NOWSince 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every d...Banyan Hill Publishing | SponsoredElon Musk about to bankrupt Amazon, Microsoft & Google?Jeff Brown, the former tech executive who called the rise of Bitcoin, Tesla, and Nvidia years early, is tracki...Brownstone Research | Sponsored$0. Later: $29.97.Bill Poulos is giving away his Simple Options Trading For Beginners book through a temporary link. Once that l...Profits Run | SponsoredDon't lose access to thisIan Cooper's guide, 'The $50-to-$500 Options Strategy,' is still available for free download, but not for long...TradeWins | SponsoredCritical SpaceX supplier w/ patented tech trading for $5President Trump's December executive order declared space a national security and economic priority, fueling a...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Microbot Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Microbot Medical With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
